Catalyst Wire Dossier Catalyst Wire Dossier

Jornay PM

methylphenidate hydrochloride extended-release
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Jornay PM, covering 2025-06-25 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening [Phase 4]

See pricing